NIH Launches Research Network To Evaluate Emerging Cancer Screening Technologies – Liver Cancer News
This landmark announcement from the White House follows ongoing advocacy efforts, including a letter to President Joe Biden sent by Prevent Cancer Foundation, GLI, and 80 other advocacy groups to establish Cancer Prevention and Early Detection Month.
Healthy Eating, Healthy Liver: The Links Between Nutrition and Liver Wellness
Maintaining optimal liver health is crucial, given the liver’s pivotal role as a major detoxifying organ. The liver, being a primary filter of toxins and chemicals that pass through the body, is influenced by an individual’s dietary choices.
Media Kit: Preparing for First US Approval of NASH Therapy
Our press kit explains the core facts of the GLI, the Resmetirom launch, and why it’s important (especially to patients) to journalists/reporters/the media in a neat, digestible package.
7th Annual Global Fatty Liver Day is less than 3 months away!
Fatty liver disease is a widespread issue that often goes undetected until it’s too late. It impacts millions worldwide leading to missed opportunities for early intervention and prevention. Studies highlight a concerning gap in identifying patients within the healthcare system who may have fatty liver disease unknowingly. We cannot afford to overlook the silent nature of this and this is why we are advocating for immediate action.
GLI Commends Repurposed Livmarli’s FDA Approval for Patients over 5 with PFIC
(Washington, D.C. March 14, 2024) –Global Liver Institute (GLI) celebrates a win for rare disease patients with the breaking news of the U.S. FDA’s approval for Mirum Pharmaceuticals’ Livmarli to treat cholestasis pruritus in patients 5 and older that have been diagnosed with progressive familial intrahepatic cholestasis (PFIC), a rare, genetic disorder in which bile builds up in the liver.